150 related articles for article (PubMed ID: 7476084)
1. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.
Hagberg G; Burlina AP; Mader I; Roser W; Radue EW; Seelig J
Magn Reson Med; 1995 Aug; 34(2):242-52. PubMed ID: 7476084
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
3. Potential of MR spectroscopy for assessment of glioma grading.
Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
[TBL] [Abstract][Full Text] [Related]
4. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.
Castillo M; Green C; Kwock L; Smith K; Wilson D; Schiro S; Greenwood R
AJNR Am J Neuroradiol; 1995 Jan; 16(1):141-7. PubMed ID: 7900583
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
Zeng Q; Liu H; Zhang K; Li C; Zhou G
Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
[TBL] [Abstract][Full Text] [Related]
6. Assignment of glial brain tumors in humans by in vivo 1H-magnetic resonance spectroscopy and multidimensional metabolic classification.
Roser W; Hagberg G; Mader I; Dellas S; Seelig J; Radue EW; Steinbrich W
MAGMA; 1997 Sep; 5(3):179-83. PubMed ID: 9351021
[TBL] [Abstract][Full Text] [Related]
7. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.
Meyerand ME; Pipas JM; Mamourian A; Tosteson TD; Dunn JF
AJNR Am J Neuroradiol; 1999 Jan; 20(1):117-23. PubMed ID: 9974066
[TBL] [Abstract][Full Text] [Related]
8. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
9. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
10. Classification of malignant gliomas by infrared spectroscopy and linear discriminant analysis.
Krafft C; Thümmler K; Sobottka SB; Schackert G; Salzer R
Biopolymers; 2006 Jul; 82(4):301-5. PubMed ID: 16506167
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.
McKnight TR
Semin Oncol; 2004 Oct; 31(5):605-17. PubMed ID: 15497114
[TBL] [Abstract][Full Text] [Related]
13. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
[TBL] [Abstract][Full Text] [Related]
14. Independent component analysis to proton spectroscopic imaging data of human brain tumours.
Pulkkinen J; Häkkinen AM; Lundbom N; Paetau A; Kauppinen RA; Hiltunen Y
Eur J Radiol; 2005 Nov; 56(2):160-4. PubMed ID: 16233889
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural cytopathology of human cerebral gliomas.
Hossmann KA; Wechsler W
Oncology; 1971; 25(5):455-80. PubMed ID: 4335473
[No Abstract] [Full Text] [Related]
16. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.
Negendank WG; Sauter R; Brown TR; Evelhoch JL; Falini A; Gotsis ED; Heerschap A; Kamada K; Lee BC; Mengeot MM; Moser E; Padavic-Shaller KA; Sanders JA; Spraggins TA; Stillman AE; Terwey B; Vogl TJ; Wicklow K; Zimmerman RA
J Neurosurg; 1996 Mar; 84(3):449-58. PubMed ID: 8609557
[TBL] [Abstract][Full Text] [Related]
17. Effect of voxel position on single-voxel MR spectroscopy findings.
Ricci PE; Pitt A; Keller PJ; Coons SW; Heiserman JE
AJNR Am J Neuroradiol; 2000 Feb; 21(2):367-74. PubMed ID: 10696025
[TBL] [Abstract][Full Text] [Related]
18. [Proton magnetic resonance spectroscopy (1H-MRS) for the diagnosis of brain tumors and the evaluation of treatment].
Grand S; Tropres I; Hoffmann D; Ziegler A; Le Bas JF
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):299-308. PubMed ID: 16292174
[TBL] [Abstract][Full Text] [Related]
19. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Kinoshita Y; Yokota A
NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
[TBL] [Abstract][Full Text] [Related]
20. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
